Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia

Nat Commun. 2022 Nov 3;13(1):6427. doi: 10.1038/s41467-022-33797-6.

Abstract

Postsynaptic density is reduced in schizophrenia, and risk variants increasing complement component 4A (C4A) gene expression are linked to excessive synapse elimination. In two independent cohorts, we show that cerebrospinal fluid (CSF) C4A concentration is elevated in patients with first-episode psychosis (FEP) who develop schizophrenia (FEP-SCZ: median 0.41 fmol/ul [CI = 0.34-0.45], FEP-non-SCZ: median 0.29 fmol/ul [CI = 0.22-0.35], healthy controls: median 0.28 [CI = 0.24-0.33]). We show that the CSF elevation of C4A in FEP-SCZ exceeds what can be expected from genetic risk variance in the C4 locus, and in patient-derived cellular models we identify a mechanism dependent on the disease-associated cytokines interleukin (IL)-1beta and IL-6 to selectively increase neuronal C4A mRNA expression. In patient-derived CSF, we confirm that IL-1beta correlates with C4A controlled for genetically predicted C4A RNA expression (r = 0.39; CI: 0.01-0.68). These results suggest a role of C4A in early schizophrenia pathophysiology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Complement C4a / cerebrospinal fluid
  • Complement C4a / genetics
  • Humans
  • Psychotic Disorders* / genetics
  • Risk Factors
  • Schizophrenia* / genetics
  • Schizophrenia* / metabolism

Substances

  • Complement C4a